Coagulation Disorders near Brandon, FL
We found 181 results within 10 miles for "Coagulation Disorders near Brandon, FL"
- Appt. wasn't rushed (1)
- Listened/answered questions (1)
- Explains conditions well (1)
- View 1 more provider attributes
- Offers Telehealth
Care Philosophy: Dr Locke is a medical oncologist and translational researcher in the Department of Blood and Marrow Transplant and Cellular Immunotherapy. He leads the Immune Cell Therapy (ICE-T) initiative at Moffitt, an integrated cross-departmental translational team. Dr Locke is a clinical research leader in the field of Chimeric Antigen Receptor (CAR) T cell therapy, acting as a national P.I. for several pivotal trials of anti-CD19 CARs for lymphoma. In addition, Dr Locke is translating findings from his laboratory into new cellular immunotherapies such as the Moffitt created whole protein survivin tumor vaccine for multiple myeloma. Dr Locke graduated with a B.S.

- Found trustworthy (5)
- Appt. wasn't rushed (3)
- Listened/answered questions (3)
- View 2 more provider attributes
- Offers Telehealth
Care Philosophy: Dr Ochoa-Bayona's interests are in traditional bone marrow transplant using high dose chemotherapy and autologous or allogeneic stem transplant to treat myeloma, lymphoma, advanced or recurrent germ cell tumors of the ovary and testis despite standard chemotherapy, myelodysplastic syndromes, acute and chronic leukemias. He completed his training in Internal Medicine, Hematology/Medical Oncology and Hematopoietic Stem Cell Transplantation from the University of Texas Health Science Center at San Antonio in 2002.

- Found trustworthy (1)
- Offers Telehealth
Care Philosophy: Dr Bejanyan is an Associate Member, Program Leader of Blood and Marrow Transplant (BMT) and Head of the Leukemia/Myeloid Section of the BMT and Cellular Immunotherapy Department at Moffitt Cancer Center. She is an Associate Professor in Oncologic Sciences at the University of South Florida.Dr Bejanyan also served as the Clinical Scientific Co-Director of Moffitt Pharmacokinetics and Pharmacodynamics Core. As a physician investigator with clinical and research expertise in BMT and cellular immunotherapies for acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS), Dr Bejanyan focuses in advancing clinical and translational research by fostering innovative immune cell therapy strategies to treat leukemia.

- Found trustworthy (22)
- Listened/answered questions (6)
- Explains conditions well (6)
- Offers Telehealth
Care Philosophy: Dr Komrokji is the Vice chair of the Malignant Hematology Department and the head of the Leukemia and MDS Section at Moffitt Cancer Center. He is a senior Member of the Malignant Hematology and Experimental Therapeutics Program at the center, and a Professor in Medicine & Oncologic Sciences at the College of Medicine at the University of South Florida, in Tampa, Florida. After earning a medical degree in 1996 from the Jordan University School of Medicine, Dr Komrokji completed an internship and residency at Case Western University, St. Vincent Program. He then completed a fellowship at Strong Memorial Hospital, University of Rochester, in Hematology/Oncology and Hematopoietic Stem Cell Transplantation.

- Explains conditions well (42)
- Found trustworthy (42)
- Listened/answered questions (41)
- View 2 more provider attributes
- Offers Telehealth

- Appt. wasn't rushed (3)
- Listened/answered questions (3)
- Explains conditions well (3)
- View 1 more provider attributes
Care Philosophy: Dr. Fletcheris an Associate Professor of Medicine within the Division of Hematology and Oncology. He is a Veterans Administration Advanced Career Development Awardee, American Heart Association Career Development Awardee and Florida Biomedical Research Program NIR Awardee.

- Listened/answered questions (36)
- Explains conditions well (36)
- Found trustworthy (36)
- View 2 more provider attributes
- Offers Telehealth

- Found trustworthy (26)
- Appt. wasn't rushed (25)
- Listened/answered questions (25)
- View 2 more provider attributes
- Offers Telehealth

- Found trustworthy (11)
- Listened/answered questions (1)
- Offers Telehealth
Care Philosophy: Dr Christine Sam is an Assistant Member in the Department of Individualized Cancer Management/Senior Adult Oncology Program. Dr Sam received her medical degree from Michigan State University College of Human Medicine in East Lansing. She completed an Internal Medicine Residency at University of Michigan Health Systems in Ann Arbor. She completed her Hematology and Medical Oncology Fellowship at Moffitt Cancer Center/University of South Florida Morsani College of Medicine in Tampa. Dr Sam's primary clinical interest is the treatment of cancer in older patients and developing care plans tailored to their individual needs. Her focus is the treatment of breast, gastrointestinal, and genitourinary malignancies.

- Found trustworthy (40)
- Appt. wasn't rushed (5)
- Listened/answered questions (5)
- View 1 more provider attributes
- Offers Telehealth
Care Philosophy: Dr Kubal is an associate member in the Moffitt Cancer Center Malignant Hematology Department. He completed his hematology/oncology fellowship at the University of South Florida at Moffitt Cancer Center, completing an MBA concurrently at the University of South Florida. Dr Kubal's research and clinical interests are in myeloid malignancies with a particular focus in acute leukemias. In addition to his clinical efforts, Dr Kubal serves as the medical director of process excellence and is focused on continuous improvement of the patient experience.Dr Kubal serves as Senior Medical Director of Moffitt at Wesley Chapel, and practices full time at the Moffitt Wesley Chapel campus.

- Found trustworthy (84)
- Listened/answered questions (82)
- Explains conditions well (82)
- View 2 more provider attributes
- Offers Telehealth

- Found trustworthy (13)
- Appt. wasn't rushed (4)
- Listened/answered questions (4)
- View 1 more provider attributes
- Offers Telehealth
Care Philosophy: Dr Lancet, a Senior Member and Professor at Moffitt Cancer Center and Chair of the Department of Malignant Hematology, is well known for his expertise in the care of patients with acute myeloid leukemia (AML), myelodysplastic syndromes (MDS), myeloproliferative neoplasms, and other related hematologic cancers. He has a special interest in the care of older adults with these diseases and also leads the Leukemia Program here at Moffitt, where he has built a large portfolio of clinical trials for patients with AML and MDS. Dr Lancet completed his residency training in Internal Medicine and Hematology-Oncology fellowship at the University of Rochester (New York), before relocating to Moffitt Cancer Center in 2004.

- Found trustworthy (16)
- Appt. wasn't rushed (3)
- Listened/answered questions (3)
- View 1 more provider attributes
- Offers Telehealth
Care Philosophy: Dr Walker received her MD from University of Rochester School of Medicine and Dentistry. She completed an Internal Medicine Residency and a Hematology/Oncology Fellowship at the University of Rochester, New York. She joins us from The Ohio State University, where she served as a Professor in the Department of Internal Medicine, Division of Hematology. Dr Walker's clinical interests are in the care of patients with myeloid malignancies, specifically acute myeloid leukemia and myelodysplastic syndromes. She is particularly interested in identifying ways to deliver care that maximizes resource utilization and achieves superior patient satisfaction.

- Found trustworthy (15)
- Appt. wasn't rushed (2)
- Listened/answered questions (2)
- View 2 more provider attributes
- Offers Telehealth
Care Philosophy: Dr Kuykendall is an Assistant Member at Moffitt Cancer Center in the Department of Malignant Hematology. He earned his MD from University of Florida College of Medicine and completed an Internal Medicine residency at the University of South Florida and a subsequent Hematology and Medical Oncology fellowship at Moffitt Cancer Center/University of South Florida. He primarily focuses his clinical and research efforts on myeloproliferative neoplasms (MPNs), MDS/MPN overlap syndromes and systemic mastocytosis (SM) where he is dedicated to developing novel, disease-modifying therapies for these rare diseases.

- Found trustworthy (1)
Care Philosophy: Dr Enas Abdallah is an Assistant Member in the Moffitt Cancer Center Department of Malignant Hematology. Dr Abdallah earned her MD from Ain Shams University in Cairo, Egypt. She completed an Internal Medicine Residency at Henry Ford Allegiance Health and a Geriatric Medicine Fellowship at Beaumont Health in Michigan. Dr Abdallah's clinical and scholarly interests are focused on inpatient management of malignant hematology patients. She will work closely with all members of the inpatient team to optimize care and outcomes.

- Found trustworthy (4)
- Appt. wasn't rushed (3)
- Listened/answered questions (3)
- View 1 more provider attributes
- Offers Telehealth
Care Philosophy: Dr Khimani's Clinical interest is specifically in Blood and Marrow transplantation. His area of focus is Lymphoma and Acute Leukemia. He routinely takes care of patients with Hodgkin's lymphoma, Non-Hodgkin's lymphoma, Acute Myeloid leukemia, acute lymphoblastic leukemia and myelodysplastic syndrome etc. who require autologous or allogeneic hematopoietic stem cell transplantation as a curative treatment option for their malignancy.

- Found trustworthy (6)
- Offers Telehealth
Care Philosophy: Dr David Sallman is an Assistant Member in the Department of Malignant Hematology at Moffitt Cancer Center. Dr Sallman's clinical interests are myelodysplastic syndromes (MDS), acute myeloid leukemia (AML) and myeloproliferative neoplasms (MPN). Dr Sallman earned his MD degree from the University of South Florida College of Medicine. He completed an Internal Medicine Residency at Massachusetts General Hospital and, most recently, a Hematology/Oncology Fellowship at Moffitt Cancer Center.

- Found trustworthy (10)
- Appt. wasn't rushed (9)
- Listened/answered questions (9)
- View 1 more provider attributes
- Offers Telehealth
Care Philosophy: Dr Pinilla-Ibarz has been at Moffitt since 2006 and holds the rank of Senior Member and Head of Lymphoma Section in the Department of Malignant Hematology. Dr Pinilla-Ibarz received the 2016-17 Moffitt Physician of the Year Award. He was also the recipient of the ASCO young investigator award in 2003 and the ASCO career development award in 2007. Dr Pinilla-Ibarz is nationally and internationally known for his expertise in chronic leukemia and he currently has over 120 peer-reviewed publications. He has received grant support through the Leukemia & Lymphoma Society and also from multiple industry partners. His clinical interests include chronic myeloid leukemia and chronic lymphoid leukemia.

- Listened/answered questions (6)
- Explains conditions well (6)
- Appt. wasn't rushed (5)
- Offers Telehealth
Care Philosophy: Gustavo Rivero, MD, is a dual fellowship-trained hematology and medical oncologist specializing in the treatment of acute and chronic leukemia. Dr Riveros areas of clinical expertise includes: acute and chronic myeloid leukemias, acute lymphoid leukemias, myelodysplastic syndrome, myeloproliferative neoplasm, and clonal hematopoiesis of indetermined potential (CHIP).

- Found trustworthy (10)
- Appt. wasn't rushed (9)
- Listened/answered questions (9)
- View 2 more provider attributes
- Offers Telehealth

- Found trustworthy (22)
- Appt. wasn't rushed (8)
- Explains conditions well (8)
- View 2 more provider attributes
- Offers Telehealth
Care Philosophy: Dr Rachid Baz is a board-certified hematologist and medical oncologist who came to Moffitt in 2008 from Cleveland Clinic. Currently, Dr Baz is the Myeloma Section Head in the Department of Malignant Hematology at Moffitt Cancer Center and co-Director of the Pentecost Family Myeloma Research Center. He has developed a special expertise in managing patients with plasma cell disorders such as multiple myeloma, monoclonal gammopathy of undetermined significance (MGUS), plasmacytoma, primary systematic amyloidosis, and Waldenstrom's macroglobulinemia (WM). Among other awards, he was the recipient of the Junior Clinical Science Award at Moffitt, and the University of South Florida Outstanding Resident Teaching Award.

- Found trustworthy (13)
- Appt. wasn't rushed (8)
- Listened/answered questions (8)
- View 1 more provider attributes
- Offers Telehealth
Care Philosophy: Dr Bijal Shah is an Associate Member in the Department of Malignant Hematology. Dr Shah's primary clinical interests are in Non-Hodgkin Lymphomas (particularly mantle cell lymphoma) and Acute Lymphoblastic Leukemia. As an internist and pediatrician, Dr Shah also has a special interest in adolescent and young adult malignant hematology.

- Offers Telehealth
Care Philosophy: Dr Michael Jain is an Associate Member and ICE-T Medical Director in the Moffitt Cancer Center Department of Blood and Marrow Transplant and Cellular Immunotherapy. Dr Jain earned his MD and PhD at McGill University in Montrv©al, in the province of Quv©bec, Canada. His PhD in Cell Biology was completed under the supervision of Dr John Bergeron. Dr Jain completed an Internal Medicine Residency and a Hematology Residency at the University of Toronto. He completed a Clinician Scientist Training Program and Clinical Fellowship in Lymphoma and Autologous Stem Cell Transplantation at Princess Margaret Cancer Center, University of Toronto.

- Appt. wasn't rushed (27)
- Listened/answered questions (27)
- Explains conditions well (27)
- View 2 more provider attributes
- Offers Telehealth

- Found trustworthy (5)
- Appt. wasn't rushed (3)
- Listened/answered questions (3)
- View 2 more provider attributes
- Offers Telehealth
Care Philosophy: Dr Ochoa-Bayona's interests are in traditional bone marrow transplant using high dose chemotherapy and autologous or allogeneic stem transplant to treat myeloma, lymphoma, advanced or recurrent germ cell tumors of the ovary and testis despite standard chemotherapy, myelodysplastic syndromes, acute and chronic leukemias. He completed his training in Internal Medicine, Hematology/Medical Oncology and Hematopoietic Stem Cell Transplantation from the University of Texas Health Science Center at San Antonio in 2002.
